Posted On: 07/30/2014 10:06:35 AM
Post# of 10471
$CBIS Tue, 27 May 2014 12:11:00 GMT ~ Cannabis Science Inc. Moves Forward with MEDIWIET Preparing Observational Study in the Netherlands
[PR Newswire] - COLORADO SPRINGS, Colo., May 27, 2014 /PRNewswire/ -- Cannabis Science, Inc. (CBIS), a U.S. Company specializing in the development of cannabis based medicine, is working closely with Mediwiet and its founder, Mr. Wernard Bruining, on the building blocks necessary for the launch of the Clinical Observational Study, as previously announced. "Over 3000 people have contacted Mediwiet and the numbers are growing," stated Mr. Mario Lap, President of European Operations and Director of Cannabis Science B.V. Mediwiet patients, unlike most who receive medicinal cannabis distributed by pharmacies or dispensaries in the Netherlands, only use non-smokable, orally taken, cannabis products. The observational study will aim to provide observational data from patients who use cannabis products seeking treatment of pain and a wide range of severe illnesses such as cancer, Alzheimer's disease, Parkinson's disease, epilepsy and multiple sclerosis.
read full: http://finance.yahoo.com/news/cannabis-scienc...00695.html
[PR Newswire] - COLORADO SPRINGS, Colo., May 27, 2014 /PRNewswire/ -- Cannabis Science, Inc. (CBIS), a U.S. Company specializing in the development of cannabis based medicine, is working closely with Mediwiet and its founder, Mr. Wernard Bruining, on the building blocks necessary for the launch of the Clinical Observational Study, as previously announced. "Over 3000 people have contacted Mediwiet and the numbers are growing," stated Mr. Mario Lap, President of European Operations and Director of Cannabis Science B.V. Mediwiet patients, unlike most who receive medicinal cannabis distributed by pharmacies or dispensaries in the Netherlands, only use non-smokable, orally taken, cannabis products. The observational study will aim to provide observational data from patients who use cannabis products seeking treatment of pain and a wide range of severe illnesses such as cancer, Alzheimer's disease, Parkinson's disease, epilepsy and multiple sclerosis.
read full: http://finance.yahoo.com/news/cannabis-scienc...00695.html
(0)
(0)
